News

Experts Discuss Future of Cannabis Businesses Post-280E

Experts Discuss Future of Cannabis Businesses Post-280E

Future of Cannabis Businesses Without 280E Restrictions

The cannabis industry stands on the brink of transformation as experts discuss the implications of removing Section 280E of the Internal Revenue Code. This tax provision, which prevents cannabis companies from deducting common business expenses, has long stifled their potential for growth.

Insights from Industry Leaders

At a recent industry conference, Darren Weiss, president of Verano Holdings Corp. (NASDAQ: VRNOF), highlighted the significant advantages that can arise once the heavy burden of 280E is lifted. According to Weiss, cannabis companies will finally operate like other businesses, allowing for more flexibility and investment in research and development.

Weiss elaborated on how freeing up capital could lead to advancements in scientific research, an area that has not been a primary focus within the cannabis sector so far. He emphasized that even single-state operators would benefit from this financial relief, enhancing their prospects and sustainability.

Panel Discussion on Industry Impact

A panel consisting of industry veterans also included Laurie Holcomb, CEO of Gold Flora Corp (OTC: GRAM), and Mackenzie Peterson, VP of marketing at AdvisorShares Pure US Cannabis ETF (NYSE: MSOS). They joined Weiss in exploring the broader implications of a post-280E world.

Financial Opportunities Unlocked

Peterson noted that if 280E were to disappear, cannabis companies would not only gain cash flow but also become more appealing to investors. Without the complexities of the tax code weighing them down, these businesses could capitalize on new opportunities, making them look more attractive in the eyes of potential backers.

Rescheduling Cannabis and Its Importance

Another critical topic discussed was the rescheduling of cannabis, a pivotal change that could coincide with the repeal of 280E. While there are hopeful indicators of progress, Peterson cautioned that significant changes may not occur as soon as 2024. Nevertheless, the political landscape does appear more favorable, especially with both leading presidential candidates showing support for cannabis reforms.

Transformative Changes Ahead

Chicago Atlantic's Peter Sack, who manages a lending company focused on the cannabis industry, praised the endorsement of rescheduling by former President Donald Trump as a watershed moment. This shift could transform the funding landscape for cannabis businesses, making lenders more inclined to invest.

Addressing Illicit Markets

Holcomb added that changes in cannabis policy would not only stabilize legitimate businesses but also help combat illegal sales. A key challenge remains the disparity in pricing between legal and illegal operators, particularly in markets like California. Holcomb believes that addressing the local and state tax burdens alongside 280E could help level the playing field.

Building a Better Marketplace

As California aims to expand its number of licensed stores from around one thousand to three thousand, there is a clear path toward competitive pricing. This growth would be essential for creating a robust legal marketplace that can effectively challenge illicit operations.

Frequently Asked Questions

What is Section 280E?

Section 280E is a part of the Internal Revenue Code that restricts cannabis businesses from deducting typical business expenses, impacting their profitability.

How would the removal of 280E affect cannabis companies?

Removing 280E would enable cannabis firms to operate more like other companies, allowing them to deduct normal business expenses and invest more in growth and research.

What is the future of cannabis rescheduling?

The potential rescheduling of cannabis could happen in conjunction with the removal of 280E, but significant changes may not occur as soon as 2024.

Who are the industry experts discussing these changes?

Industry leaders like Darren Weiss of Verano Holdings, Laurie Holcomb of Gold Flora, and Mackenzie Peterson of AdvisorShares are analyzing the future of cannabis following these regulatory changes.

What are the potential benefits of rescheduling cannabis?

Rescheduling cannabis could facilitate easier access to capital for businesses and allow for more robust scientific research and development initiatives.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 83

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 253

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 231

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 86

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 190

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 443

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 321

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading

Top 5 Most Recently Viewed Articles

Brand Engagement Network Welcomes Janine Grasso as New Leader

Updated Category News Views 154

Janine Grasso Takes the Helm at Brand Engagement Network Brand Engagement Network Inc. (NASDAQ: BNAI), a renowned player in the realm of AI-powered customer engagement, is excited to announce the appointment of Janine Grasso as the new Interim Chief Executive Officer. This transition marks a significant moment for the company as it continues to strengthen its leadership...

Continue Reading
Three Stocks Primed for Growth Amid Changing Inflation

Updated Category News Views 78

Understanding the Impact of Inflation on Stocks Inflation has a profound effect on the stock market, influencing investor psychology and pricing strategies across sectors. When inflation rises, many businesses experience greater earnings potential due to increased pricing power. However, when inflation begins to soften, some stocks may struggle while others adapt more...

Continue Reading
Datarails Unveils Fun Panda Mascot to Engage CFOs and Teams

Updated Category News Views 251

Datarails Introduces a Unique Panda Mascot Datarails has recently taken a creative approach in connecting with CFOs and their teams by introducing a vibrant panda mascot. This initiative showcases the company's commitment to making financial planning and analysis both engaging and relatable. Bringing a Playful Edge to Financial Challenges The newly launched panda mascot...

Continue Reading
LegalShield's Latest Index Insights Indicate Election Trends

Updated Category News Views 106

LegalShield's Consumer Stress Legal Index: A New Perspective ADA, Okla.—LegalShield's recent analysis of the Consumer Stress Legal Index (CSLI) seems to point towards a win for Democratic candidates in upcoming elections. Tracking around 150,000 calls every month from individuals seeking legal assistance, this index has accurately correlated with past presidential...

Continue Reading
Unveiling MySmile's Exciting Summer Sale: Shine Bright

Updated Category News Views 153

MySmile Oral Care Invites You to a Summer Smile Celebration Ready to transform your smile this summer? MySmile Oral Care is thrilled to announce a fantastic opportunity to enjoy 20% off sitewide during their limited-time Summer Smile Sale. With only hours left to take advantage of this deal, now is the perfect moment to elevate your oral care routine. Why You Should Join...

Continue Reading